The value-case lens — a turnaround, not an exit: the combined-ratio path to <110%, the ₹10,000 Cr GWP ambition, the solvency-capital build and the readiness to get there. Private & unlisted — no market cap or share price.
The value case is a turnaround, not an exit: bend the 112.5% combined ratio to a <110% target, monetise the Central Bank bancassurance channel and hold solvency ≥1.50× to scale GWP from ₹5.55k Cr toward the ₹10.00k Cr ambition. The marquee block is the ~99% health loss ratio; clear the lowest-readiness item (Path to ₹10,000 Cr GWP by ~FY30 at 45%) before the board pack goes out. Private & unlisted — no market cap, no share price.
3 of 4 headline metrics improving vs prior · still off target: Profit After Tax (PAT) ₹94 Cr vs ₹150 Cr, Investment Income ₹598 Cr vs ₹650 Cr, Policy Retention 82.0% vs 85.0%
Drive the turnaround to <110%: health pricing, motor-OD discipline, EOM cap & fraud control.
FY25 combined ratio worsened to 112% (from 106%) as net incurred claims jumped +23%; the ~₹471 Cr underwriting loss is only covered by investment income.
The 112.5% combined ratio is an underwriting loss; the health loss-ratio fix (−2pt) and motor-OD & EOM efficiencies (−1pt) chart the path to a 109.5% target — on top of the ₹598 Cr investment income that keeps PAT positive.
The lowest-% turnaround-readiness item is the top execution risk: ₹5,548 Cr today; ambition ~doubles — bancassurance + health/motor + digital.
Track board reconstitution, bancassurance integration milestones & brand transition.
Central Bank of India joined as 26.14% co-promoter (Jun-2025) and the JV rebranded to Generali Central (Aug-2025); expect CBI nominee directors & title changes.
The cockpit is strong day-to-day — but this is the value-case lens. It cuts through to what makes the turnaround land: the combined-ratio path to <110%, the ₹10,000 Cr GWP ambition, the solvency-capital build and the readiness items behind them. Private & unlisted — the value is a healthier combined ratio and a bigger, profitable book, not a share price. At 112.5% combined ratio today, ₹5.55k Cr of GWP and solvency 1.96× frame the whole conversation.
Net loss ratio → + commission → + expense = combined ratio 112% → health loss-ratio fix → motor-OD & EOM → target combined ratio <110%.
So what: the 112.5% combined ratio is an underwriting loss — the health loss-ratio fix (−2pt) and motor-OD / EOM efficiencies (−1pt) chart a 3pt path to a 109.5% target. That flips underwriting back toward breakeven, on top of the ₹598 Cr of investment income that already keeps PAT positive.
FY25 GWP → motor & health profitable growth → Central Bank bancassurance scale-up → mid-plan (~FY28) → commercial, crop, rural & digital → ambition GWP (~FY30).
Growth ambition: FY25 GWP of ₹5.55k Cr roughly doubles to ₹10.00k Cr by ~FY30 — motor & health profitable growth plus the Central Bank bancassurance scale-up carry it to a ₹9.05k Cr mid-plan, with commercial, crop, rural & digital closing the gap. Private & unlisted: this is a premium-scale ambition, not a market cap.
Available solvency margin (ASM) grows with capital generation as the book scales; solvency held comfortably above the 1.50× IRDAI floor through the growth ramp.
| Period | Beg ASM | Capital gen | End ASM | RSM | Solvency | Kind |
|---|---|---|---|---|---|---|
| Q4 FY25 (act) | ₹1.84k Cr | +₹56 Cr | ₹1.90k Cr | ₹965 Cr | 1.96× | Actual |
| Q1 FY26 | ₹1.90k Cr | +₹34 Cr | ₹1.93k Cr | ₹985 Cr | 1.96× | Forecast |
| Q2 FY26 | ₹1.93k Cr | +₹40 Cr | ₹1.97k Cr | ₹1.00k Cr | 1.96× | Forecast |
| Q3 FY26 | ₹1.97k Cr | +₹45 Cr | ₹2.02k Cr | ₹1.02k Cr | 1.97× | Forecast |
| Q4 FY26 | ₹2.02k Cr | +₹50 Cr | ₹2.06k Cr | ₹1.04k Cr | 1.98× | Forecast |
| FY27 target | ₹2.06k Cr | +₹85 Cr | ₹2.15k Cr | ₹1.07k Cr | 2.00× | Forecast |
Available solvency margin ₹1,896 Cr vs required ₹965 Cr (1.96×); net worth (paid-up capital + reserves) plus ₹517 Cr Tier-2 sub-debt underpin it — capital, not operating leverage.
| Component | Kind | Balance | Rate | Maturity | Note |
|---|---|---|---|---|---|
| Available Solvency Margin (ASM) | Solvency | ₹1.90k Cr | — | — | vs Required Solvency Margin ₹965 Cr → solvency ratio 1.96× (196%), well above the 150% IRDAI floor. |
| Paid-up equity share capital | Equity | ₹1.21k Cr | — | Permanent | 1,206.4 cr shares of ₹10; a 1:6 bonus (₹201 Cr) was issued post year-end. |
| Subordinated debt (NCDs) — Tier-2 solvency capital | Sub-debt | ₹517 Cr | ~8.9% | 2028-2032 | Counts toward the solvency margin — CAPITAL, not operating leverage; no covenant-leverage stress. |
| Reserves & surplus | Reserves | ₹348 Cr | — | Permanent | Retained earnings + share premium; with paid-up capital = net worth ~₹1,554 Cr. |
Policy retention dips as a line scales, then recovers as the book seasons.
| Line | Since | Retention at start | Yr 1 (dip) | Retention now | Yr-1 lapse | Note |
|---|---|---|---|---|---|---|
| Motor — Private Car & Two-Wheeler | 2007 | 80% | 82% | 85% | 18% | Sticky retail motor; TP obligation anchors the book. |
| Commercial (Fire / Marine / Engineering) | 2007 | 70% | 68% | 72% | 28% | Broker-driven; soft pricing pressures retention. |
| Group Health & Corporate | 2009 | 74% | 72% | 76% | 26% | Corporate churn on repricing; walking away from loss-making accounts. |
| Retail Health (Total / Vital / PowHer) | 2010 | 78% | 80% | 83% | 20% | Retail health retains well; medical-inflation pricing is the risk. |
| PA & Rural (Alpa Bima) | 2012 | 72% | 74% | 80% | 22% | Profitable PA + rural/social cover; growing retention. |
| Weather / Crop | 2016 | 60% | 55% | 62% | 35% | Tender/scheme-driven; volatile participation year to year. |
New lines dip early as they scale, then season back up as the book matures — except Weather/Crop, where tender/scheme-driven participation keeps retention volatile and low — the one soft spot the board will probe in the revenue-quality pack.
The top execution risk is the lowest-% item — Path to ₹10,000 Cr GWP by ~FY30 (45%): ₹5,548 Cr today; ambition ~doubles — bancassurance + health/motor + digital.